Intellia Therapeutics, Inc. Stock History: The Story of a CRISPR Gene Editing Pioneer

Intellia Therapeutics, Inc. Stock History: The Story of a CRISPR Gene Editing Pioneer

Source: 
Motley Fool
snippet: 

Gene editing holds the promise to revolutionize healthcare. But there are only a handful of stocks available for investing in the technology. One of the leaders is Intellia Therapeutics, Inc.